CORINNE SPERO: Open Payments
NPI 1184171563 · BOTHELL, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,939 in 95 payments from 15 companies in 2025. Trend: 2023 $2,454 · 2024 $2,515 · 2025 $2,939
Food & beverage: $2,853Education: $86
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 21 | $732 |
| ABBVIE INC. | 23 | $621 |
| Amgen Inc. | 13 | $368 |
| Janssen Scientific Affairs, LLC | 2 | $274 |
| UCB, Inc. | 8 | $257 |
| Novartis Pharmaceuticals Corporation | 7 | $167 |
| Lilly USA, LLC | 5 | $142 |
| Alexion Pharmaceuticals, Inc. | 3 | $96 |
| GlaxoSmithKline, LLC. | 3 | $68 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
Products named: TREMFYA, RINVOQ, SKYRIZI, Bimzelx, COSENTYX, EVENITY, TALTZ, KRYSTEXXA.
Industry payments across WA — which companies pay providers there.
